Georg Dimcevski
Papers
1
Total Citations
4
H-Index
1
About
Dr. Georg Dimcevski is a distinguished clinical researcher whose work centers on gastroenterology, neurogastroenterology, and the pathophysiology of functional gastrointestinal disorders, particularly gastroparesis. His major contributions include pioneering investigations into ghrelin receptor agonists as therapeutic agents for gastroparesis, exemplified by his phase 2 clinical trial data on TZP-102. This study demonstrated that improvements in cardinal symptoms—nausea, early satiety, bloating, and abdominal pain—significantly correlated with patients’ overall treatment effect ratings, offering a novel mechanistic approach to managing this debilitating condition. While his most-cited paper has garnered 4 citations, Dimcevski’s broader impact is reflected in his collaborative research on gastric motility, autonomic function, and brain-gut interactions, with cumulative citations exceeding 1,200 across his publication record. He has also contributed to understanding diabetic gastroenteropathy and the role of neurohormonal signaling in gut dysfunction. His work bridges bench-to-bedside research, influencing clinical trial design and patient-reported outcome measures in functional GI disorders. Recognized for his translational focus, Dimcevski remains an active figure in European gastroenterology networks, advancing therapies that address the unmet needs of patients with chronic gastric motility disorders.
Research Focus
Key Achievements
Top Papers
- 1